Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cardiff Oncology, Inc. | 780,008 | reported | 11 Mar 2025 | tx 2+355,008 |
| Forte Biosciences, Inc. | 20,000 | reported | 04 Oct 2019 | tx 2+120,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2025 | GRANT_AWARD | Cardiff Oncology, Inc. | 150,000 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Cardiff Oncology, Inc. | 205,008 | 0.00 USD | deriv |
| 04 Oct 2019 | GRANT_AWARD | Forte Biosciences, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Apr 2019 | GRANT_AWARD | Forte Biosciences, Inc. | 100,000 | 0.00 USD | deriv |